BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15481207)

  • 1. Delivering a selective neonatal BCG vaccination programme in a multi-ethnic community: an audit of the neonatal BCG immunisation programme in Birmingham and Solihull.
    Etuwewe O; Wood A; Lyon A
    Commun Dis Public Health; 2004 Sep; 7(3):172-6. PubMed ID: 15481207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Audit of the implementation of selective neonatal BCG immunisation in south east London.
    Tseng E; Nesbitt A; O'Sullivan D
    Commun Dis Rep CDR Rev; 1997 Oct; 7(11):R165-8. PubMed ID: 9350094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
    Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in the rates of BCG vaccination.
    Deshpande SA
    Arch Dis Child; 2004 Jan; 89(1):48-9. PubMed ID: 14709504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How good is our neonatal BCG uptake? A snapshot in Grampian.
    Shanks S; Duthie S
    J Public Health (Oxf); 2016 Jun; 38(2):e122-4. PubMed ID: 26205439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacillus Calmette-Guérin (BCG) vaccine coverage in newborns and infants at risk before and after a change in BCG policy].
    Parache C; Carcopino X; Gossot S; Retornaz K; Uters M; Mancini J; Garnier JM; Minodier P
    Arch Pediatr; 2010 Apr; 17(4):359-65. PubMed ID: 20219333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective neonatal BCG vaccination.
    Bakshi D; Sharief N
    Acta Paediatr; 2004 Sep; 93(9):1207-9. PubMed ID: 15384885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
    Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
    Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the uptake of selective neonatal BCG immunisation.
    Gill J; Scott J
    Commun Dis Public Health; 1998 Dec; 1(4):281-2. PubMed ID: 9854891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of newly introduced universal BCG vaccination in newborns.
    Braima O; Rigney A; Ryan CA; Murphy C
    Ir Med J; 2010 Jun; 103(6):187-8. PubMed ID: 20669606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
    Dierig A; Tebruegge M; Krivec U; Heininger U; Ritz N;
    Vaccine; 2015 Sep; 33(38):4994-9. PubMed ID: 26151543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and attitudes of parents and professionals to neonatal BCG vaccination in light of recent UK policy changes: a questionnaire study.
    Gordon M; Roberts H; Odeka E
    BMC Infect Dis; 2007 Jul; 7():82. PubMed ID: 17650337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing the new BCG vaccination guidelines--a maternity hospital-based clinic approach.
    Athavale D; McCullough S; Mactier H
    J Public Health (Oxf); 2006 Jun; 28(2):133-6. PubMed ID: 16549406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the coverage of neonatal BCG vaccination.
    Chappel D; Fernandes V
    J Public Health Med; 1996 Sep; 18(3):308-12. PubMed ID: 8887842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new neonatal BCG vaccination pathway in England: a mixed methods evaluation of its implementation.
    Jones K; Chisnall G; Crocker-Buque T; Elliman D; Horwood J; Mounier-Jack S; Campbell CN; Saliba V; Chantler T
    BMC Public Health; 2024 Apr; 24(1):1175. PubMed ID: 38671383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
    Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
    Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective audit of neonatal BCG vaccination in Grampian, Scotland.
    Savul S; Duthie S
    Hum Vaccin Immunother; 2023 Dec; 19(3):2281737. PubMed ID: 38175950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination of newborns with high risk of tuberculosis in a French maternity hospital].
    Dommergues MA; Robichon F; Soltane S; Refol S; Panel P; Foucaud P
    Arch Pediatr; 2009 Sep; 16(9):1270-5. PubMed ID: 19632818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG vaccination reaction in low birth weight infants.
    Kaur S; Faridi MM; Agarwal KN
    Indian J Med Res; 2002 Aug; 116():64-9. PubMed ID: 12592992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.